Status:
COMPLETED
Collection of Autologous Blood Products by Double Erythrocytapheresis
Lead Sponsor:
Sanquin Research & Blood Bank Divisions
Collaborating Sponsors:
Atrium Medical Center
Maasland Hospital
Conditions:
Pre Operative Autologous Donation
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The project will determine the advantages of double erythrocytapheresis in the collection of preoperative autologous erythrocytes as compared to the standard collections of whole blood. The study will...
Detailed Description
The project will determine the advantages of double erythrocytapheresis in the collection of preoperative autologous erythrocytes as compared to the standard collections of whole blood. The study will...
Eligibility Criteria
Inclusion
- Elective surgery
Exclusion
- Malignancies
- Severe arrhythmias
- Congestive heart failure
- Recent angina
- Epileptic seizures in the last 3 months before collection
Key Trial Info
Start Date :
September 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2007
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00202475
Start Date
September 1 2003
End Date
December 1 2007
Last Update
October 20 2009
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Sanquin Bloodbank
Maastricht, Limburg, Netherlands, 6229 GS
2
Sanquin Blood Bank Southeast Region
Maastricht, Netherlands, 6229 GR